Workflow
保健及美容产品
icon
Search documents
李嘉诚旗下屈臣氏集团:在成渝地区优化门店,持续削减人员
Sou Hu Cai Jing· 2025-08-21 00:48
Core Viewpoint - Watsons Group, under Li Ka-shing, is continuously reducing its store count in China, reflecting a strategic shift in response to declining performance in the region [2][4]. Financial Performance - In the first half of 2025, Watsons Group reported a revenue of HKD 6.666 billion in China, a year-on-year decrease of 3% [2][3]. - The EBITDA for the same period was HKD 117 million, down 53% compared to the previous year [2][3]. Store Count and Sales Performance - The number of stores in China decreased by 145, representing a 4% reduction year-on-year [4][6]. - The year-on-year sales growth rate for stores in China improved from -18.6% to -1% [4][5]. Strategic Adjustments - The reduction in store count is part of a strategy to optimize the store portfolio, closing underperforming locations upon lease expiration [6]. - The company is increasing its online fulfillment capabilities, with the number of micro-fulfillment centers rising from 131 to 394 [6]. Regional Performance - Other regions, such as Asia and Europe, are performing well, with significant growth in sales and store counts, contrasting sharply with the decline in China [3][5]. - In Asia, store count increased by 796, with a sales growth rate of 6.4% [5]. Employment Trends - The number of employees in Chengdu Watsons has decreased from 1,582 in 2022 to 1,204 in 2024, indicating a trend of workforce reduction [8]. - Similarly, in Chongqing, employee numbers have also shown a continuous decline from 600 in 2022 to 501 in 2024 [10]. Overall Strategy - The company is adopting a dual strategy of closing inefficient physical stores while expanding its online and warehousing capabilities to enhance competitive advantage amid pressures from e-commerce and local beauty stores [11].
毛利率高达75%!在香港卖保健及美容产品年入过亿,冲击IPO
格隆汇APP· 2025-08-14 10:33
Core Viewpoint - The company has achieved a gross margin of 75% and generates over 100 million in annual revenue from selling health and beauty products in Hong Kong, indicating strong market potential as it prepares for an IPO [1] Group 1 - The company specializes in health and beauty products, which have shown significant demand in the Hong Kong market [1] - The impressive gross margin of 75% highlights the company's effective cost management and pricing strategy [1] - Annual revenue exceeding 100 million demonstrates the company's established market presence and financial stability [1] Group 2 - The upcoming IPO reflects the company's growth ambitions and the potential for attracting further investment [1] - The health and beauty industry in Hong Kong is characterized by robust consumer spending, providing a favorable environment for the company's expansion [1] - The company's strong financial performance positions it well to capitalize on market opportunities post-IPO [1]